The Supervisory Board of Akzo Nobel N.V (Amsterdam, Netherlands) has announced that Keith Nichols, Chief Financial Officer, will step down from his position at the end of June 2014.
Akzo Nobel Chief Financial Officer Keith Nichols to Stand Down
The Supervisory Board of Akzo Nobel N.V (Amsterdam, Netherlands) has announced that Keith Nichols, Chief Financial Officer, will step down from his position at the end of June 2014.
Nichols said: "Making a decision like this is never easy but I leave the company well placed to deliver its 2015 financial targets. I would like to thank my colleagues throughout the company and wish them all the very best for the future."
Chief Executive Officer Ton Büchner: "We thank Keith for his dedication and commitment to AkzoNobel over the past eight years. He has played a major role in the transformation of the company's portfolio, most notably in the exit of our pharmaceutical business and, since becoming CFO in 2008, has made an outstanding contribution in driving financial discipline and functional excellence across the company.” He added: “We will miss Keith's valuable and insightful input as well as his hard work and I know that I speak on behalf of all my colleagues in wishing him well for the future."
Nichols will retain his position as CFO and remain on the Board of Management until the end of June 2014. The company is currently in the process of looking for his replacement.
For more information please visit: www.akzonobel.com
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Using Chromatography to Explore Fluorescent Bioactive Compounds in the Coelomic Fluid of Earthworms
February 6th 2025A study aiming to identify fluorescent bioactive compounds in the coelomic fluid of earthworms, as well as to investigate their structural and functional characteristics for possible use in biomedical applications, utilized a variety of chromatographic techniques.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.